Comparing the Difference in Pain Control in the Pediatric General Surgery Population: to Alternate or Combine Acetaminophen and Ibuprofen?
Launched by BAYLOR RESEARCH INSTITUTE · Jul 15, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well different pain relief methods work for children who have had general surgery, such as hernia repairs or appendectomies. Researchers want to find out if alternating doses of acetaminophen and ibuprofen every three hours is better for managing pain compared to giving both medications together around the clock.
To participate in this trial, children aged 3 to 18 who are scheduled for certain types of surgeries at McLane Children's Hospital may be eligible. However, children with allergies to acetaminophen or ibuprofen, or those who are being evaluated for non-accidental trauma, will not be able to join. If eligible, participants will receive either the alternating or combined treatment and will be closely monitored for pain relief and any side effects. This study aims to improve how we manage pain in young patients after surgery, helping them feel better faster.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age group: 3 years to 18 years
- • General surgery service (hernia, appendectomy, chole, circumcision, wounds, vacs, implanted central line, etc.)
- Exclusion Criteria:
- • Patients who are allergic to acetaminophen and/or ibuprofen
- • Patients being evaluated by SANE or evaluated for nonaccidental trauma
- • Patients admitted post-op
- • The study will take place at McLane Children's Hospital Temple Market. Patients who are pregnant.
About Baylor Research Institute
Baylor Research Institute (BRI) is a leading clinical research organization affiliated with Baylor Scott & White Health, dedicated to advancing medical knowledge and improving patient care through innovative research initiatives. With a focus on translational medicine, BRI conducts a wide range of clinical trials across various therapeutic areas, including cardiovascular, oncology, and neurology. The institute is committed to fostering collaborative partnerships with academic institutions, industry leaders, and healthcare professionals to enhance the development of novel therapies and interventions. Through rigorous scientific methodology and ethical standards, Baylor Research Institute strives to contribute significantly to the advancement of healthcare and to provide patients with access to cutting-edge treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Temple, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported